The Lovenox Benchmark: Copaxone "Far More Complex," Teva Argues In Anti-Generic Petition

Teva is using FDA’s rationale for approving generic Lovenox to argue against the approval of ANDAs for generic versions of its multiple sclerosis drug Copaxone (glatiramer).